BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24977705)

  • 21. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients.
    Li W; Jia H; Wang S; Guo X; Zhang X; Zhang L; Wen HY; Fu L
    Ann Diagn Pathol; 2022 Dec; 61():152047. PubMed ID: 36156357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Prognostic Factors and Construction of Prognostic Models for Invasive Micropapillary Carcinoma of the Breast.
    Wang X; Xue Y
    Comput Math Methods Med; 2022; 2022():1072218. PubMed ID: 36339683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of prognosis between invasive micropapillary carcinoma and invasive ductal carcinoma of breast: a single center, retrospective case-control study].
    Hua B; Lu X; Xiao WZ; Yang X; He SR; Wang Z
    Zhonghua Wai Ke Za Zhi; 2018 Jan; 56(1):56-60. PubMed ID: 29325355
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Invasive ductal carcinomas of breast showing partial reversed cell polarity are associated with lymphatic tumor spread].
    Zhao XJ; Li B; Xu JP; Wang ZY; Wang L; Zhu HY; Chu XH
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):305-8. PubMed ID: 22883668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PSCA expression in invasive micropapillary carcinoma of breast].
    Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reversed apical pattern of MUC1 expression is characteristics of invasive micropapillary carcinoma of the breast.
    Li YS; Kaneko M; Sakamoto DG; Takeshima Y; Inai K
    Breast Cancer; 2006; 13(1):58-63. PubMed ID: 16518063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast.
    Hashmi AA; Aijaz S; Mahboob R; Khan SM; Irfan M; Iftikhar N; Nisar M; Siddiqui M; Edhi MM; Faridi N; Khan A
    BMC Res Notes; 2018 Jul; 11(1):531. PubMed ID: 30064485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
    Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
    Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.
    Kuba S; Ohtani H; Yamaguchi J; Hayashi H; Uga T; Kanematsu T; Shimokawa I
    Virchows Arch; 2011 Feb; 458(2):159-69. PubMed ID: 21221635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.
    Ren M; Liu F; Zhu Y; Li Y; Lang R; Fan Y; Gu F; Zhang X; Fu L
    Virchows Arch; 2014 Sep; 465(3):291-8. PubMed ID: 24980157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
    Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
    Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of interleukin-1beta expression and microvascular density in invasive micropapillary carcinoma of breast].
    Cui LF; Guo XJ; Wei J; Liu FF; Gu F; Fan Y; Lang RG; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):599-603. PubMed ID: 19094583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients.
    Kitagawa H; Yoshimitsu M; Kaneko M; Ibuki Y; Emi M; Kohashi T; Mukaida H; Matsuura H; Ohge H; Ohdan H; Hirabayashi N
    Jpn J Clin Oncol; 2017 Dec; 47(12):1129-1134. PubMed ID: 29036423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Competing Nomogram to Predict Survival Outcomes in Invasive Micropapillary Breast Cancer.
    Li D; Zhong C; Cheng Y; Zhu N; Tan Y; Zhu L; Xu D; Yuan Y
    J Cancer; 2019; 10(27):6801-6812. PubMed ID: 31839814
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database.
    Lewis GD; Xing Y; Haque W; Patel T; Schwartz M; Chen A; Farach A; Hatch SS; Butler EB; Chang J; Teh BS
    Cancer Commun (Lond); 2019 Oct; 39(1):60. PubMed ID: 31639071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast.
    Lewis GD; Xing Y; Haque W; Patel T; Schwartz MR; Chen AC; Farach A; Hatch SS; Butler EB; Chang JC; Teh BS
    Breast J; 2019 Nov; 25(6):1171-1176. PubMed ID: 31321854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.